Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 800

The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

Open access
Zhou, Jian, Sun, Huichuan, Wang, Zheng, Cong, Wenming, Wang, Jianhua, Zeng, Mengsu, Zhou, Weiping, Bie, Ping, Liu, Lianxin, Wen, Tianfu, Han, Guohong, Wang, Maoqiang, Liu, Ruibao, Lu, Ligong, Ren, Zhengang, Chen, Minshan, Zeng, Zhaochong, Liang, Ping, Liang, Changhong, Chen, Min, Yan, Fuhua, Wang, Wenping, Ji, Yuan, Yun, Jingping, Cai, Dingfang, Chen, Yongjun, Cheng, Wenwu, Cheng, Shuqun, Dai, Chaoliu, Guo, Wenzhi, Hua, Baojin, Huang, Xiaowu, Jia, Weidong, Li, Yaming, Li, Yexiong, Liang, Jun, Liu, Tianshu, Lv, Guoyue, Mao, Yilei, Peng, Tao, Ren, Weixin, Shi, Hongcheng, Shi, Guoming, Tao, Kaishan, Wang, Wentao, Wang, Xiaoying, Wang, Zhiming, Xiang, Bangde, Xing, Baocai, Xu, Jianming, Yang, Jiamei, Yang, Jianyong, Yang, Yefa, Yang, Yunke, Ye, Shenglong, Yin, Zhengyu, Zhang, Bixiang, Zhang, Boheng, Zhang, Leida, Zhang, Shuijun, Zhang, Ti, Zhao, Yongfu, Zheng, Honggang, Zhu, Jiye, Zhu, Kangshun, Liu, Rong, Shi, Yinghong, Xiao, Yongsheng, Dai, Zhi, Teng, Gaojun, Cai, Jianqiang, Wang, Weilin, Cai, Xiujun, Li, Qiang, Shen, Feng, Qin, Shukui, Dong, Jiahong, Fan, Jia·2020·Liver Cancer

Abstract

Background: Primary liver cancer, around 90% are hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause of tumor-related death, thereby posing a significant threat to the life and health of the Chinese people. Summary: Since the publication of Guidelines for Diagnosis and Treatment of Primary Liver Cancer (2017 Edition) in 2018, additional high-quality evidence has emerged with relevance to the diagnosis, staging, and treatment of liver cancer in and outside China that requires the guidelines to be updated. The new edition (2019 Edition) was written by more than 70 experts in the field of liver cancer in China. They reflect the real-world situation in China regarding diagnosing and treating liver cancer in recent years. Key Messages: Most importantly, the new guidelines were endorsed and promulgated by the Bureau of Medical Administration of the National Health Commission of the People’s Republic of China in December 2019.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000509424

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 151 references

Cited by

See all 800

Metadata

Authors
Zhou, J., Sun, H., Wang, Z., Cong, W., Wang, J., Zeng, M., Zhou, W., Bie, P., Liu, L., Wen, T., Han, G., Wang, M., Liu, R., Lu, L., Ren, Z., Chen, M., Zeng, Z., Liang, P., Liang, C., Chen, M., Yan, F., Wang, W., Ji, Y., Yun, J., Cai, D., Chen, Y., Cheng, W., Cheng, S., Dai, C., Guo, W., Hua, B., Huang, X., Jia, W., Li, Y., Li, Y., Liang, J., Liu, T., Lv, G., Mao, Y., Peng, T., Ren, W., Shi, H., Shi, G., Tao, K., Wang, W., Wang, X., Wang, Z., Xiang, B., Xing, B., Xu, J., Yang, J., Yang, J., Yang, Y., Yang, Y., Ye, S., Yin, Z., Zhang, B., Zhang, B., Zhang, L., Zhang, S., Zhang, T., Zhao, Y., Zheng, H., Zhu, J., Zhu, K., Liu, R., Shi, Y., Xiao, Y., Dai, Z., Teng, G., Cai, J., Wang, W., Cai, X., Li, Q., Shen, F., Qin, S., Dong, J., & Fan, J.
Venue
Liver Cancer
Publisher
S. Karger AG
Published
2020
Volume
9
Issue
6
Pages
682-720
ISSN
  • 1664-5553 (ISSN-L)
  • 2235-1795
OpenAlex
W3099108820
Cited by
800
References
151
FWCI
57.10
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). https://app.cochat.ai/papers/10.1159/000509424
The paper
Zhou, J., Sun, H., Wang, Z., Cong, W., Wang, J., Zeng, M., Zhou, W., Bie, P., Liu, L., Wen, T., Han, G., Wang, M., Liu, R., Lu, L., Ren, Z., Chen, M., Zeng, Z., Liang, P., Liang, C., . . . Fan, J. (2020). Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer. https://doi.org/10.1159/000509424

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.